Investigators studied cardiotoxicities of first-line regimens for metastatic hormone-sensitive and nonmetastatic castration-resistant prostate cancer.

More research is needed to address barriers to therapeutic monitoring of prostate cancer patients on androgen deprivation ...

Hot flushes in men are sudden, intense heat waves caused by hormone therapy. Learn how to manage them effectively.

Discover new insights into testosterone recovery following androgen deprivation therapy in men undergoing radiotherapy for ...

Results from the phase 3 PEACE-3 study found that a combination therapy showed higher benefits for patients with bone ...

Local radiation therapy appears beneficial for men with bone metastatic hormone-sensitive prostate cancer (mHSPC).

Prostate cancer accounts for 3.8% of total cancer-related deaths worldwide. The combination of docetaxel and androgen deprivation therapy is useful in the management of the disease, but unfortunately, ...

Patients with metastatic prostate cancer may have improved survival outcomes after undergoing next-generation PSMA PET ...

Preliminary efficacy assessment from cohort 4 showed that all 3 participants had reductions in prostate-specific antigen (PSA) levels following 2 doses of 12GBq of 67 Cu-SAR-bisPSMA, with the largest ...

BAYRY submits an application seeking EMA approval of elinzanetant for treating hot flashes associated with menopause or ...

Bayer seeks European approval for darolutamide in combo with ADT in patients with metastatic hormone-sensitive prostate cancer: Berlin Wednesday, October 16, 2024, 13:00 Hrs [IST] ...